Humira to Amgevita - Experience from over the ditch

90 minutes to Watch
Contributor
Dr David Liew, Andrea Copeland
17 March 2022

This recorded webinar covers the introduction of the adalimumab biosimilar Amgevita in New Zealand, and what it means for primary care. Specialist Dr David Liew shares his experiences of changing patients from biologics to biosimilars in Australia, and Andrea Copeland provides some local context.

Dr David Liew is a consultant rheumatologist and clinical pharmacologist based at Austin Health, Melbourne. His research interests include immune-related adverse events from checkpoint inhibitors for cancer, polymyalgia rheumatica, value-based rational prescribing, and pharmaceutical drug safety.

Andrea Copeland is the education lead for He Ako Hiringa. She is a registered pharmacist and is passionate about health equity, public health, continuous quality improvement and clinical education.

This video is a recording of the live webinar hosted by He Ako Hiringa on 15 March 2022 and is intended for a health professional audience.

The video has been edited for clarity.

Resources mentioned in this webinar

• Our biological medicines resource hub contains content from multiple providers.
• Episodes 1 and 2 of our Legendary Conversations podcast cover initiating new medicines, and minimising the nocebo effect.
• The Amgevita website supports patients & clinicians and includes an 0800 number to connect you with nurses experienced with using Amgevita.
• The Pharmac website contains prescribing, dispensing and consumer information about adalimumab.

Professional college endorsements

This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for 1.5 CME credits for Continuing Professional Development (CPD) purposes. To claim your credits, log in to your RNZCGP dashboard to record this activity in the CME component of your CPD programme.

This activity has been endorsed by the Pharmaceutical Society of NZ Inc (PSNZ) as suitable for inclusion in a pharmacist’s CE records for Continuing Professional Development (CPD) purposes.

The College of Nurses Aotearoa (NZ) has endorsed this course for 90 minutes of professional development.

RNZCGP logoPSNZ logoCollege of Nurses Aotearoa (NZ) endorsement